Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in children under 5 years

Strumann, ChristophRanzani, OtavioMoor, JeanneBerner, ReinhardTöpfner, NicoleChao, Cho-MingMoor, Matthias B.2024-02-192024-02-192023Strumann C, Ranzani O, Moor J, Berner R, Töpfner N, Chao CM, Moor MB. Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in children under 5 years. J Clin Invest. 2023 Nov 1;133(21):e173329. DOI: 10.1172/JCI1733290021-9738http://hdl.handle.net/10230/59120application/pdfeng© 2023, Strumann et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in children under 5 yearsinfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1172/JCI173329EpidemiologyInfectious diseaseVaccinesinfo:eu-repo/semantics/openAccess